军事药房:支持民间社会的工具

Q Pharmacology, Toxicology and Pharmaceutics Anales De La Real Academia Nacional De Farmacia Pub Date : 2024-07-01 DOI:10.53519/analesranf.2024.90.02.01
Alejandro Zamanillo Sainz
{"title":"军事药房:支持民间社会的工具","authors":"Alejandro Zamanillo Sainz","doi":"10.53519/analesranf.2024.90.02.01","DOIUrl":null,"url":null,"abstract":"The partnership between the Spanish Military Pharmacy Corps and the civil society has increased in the last twenty years, when the two million smallpox vaccines acquired by the Spanish Ministry of Health were stored at the “Centro Militar de Farmacia de la Defensa” (Military Centre of Defence Pharmacy). In 2009, collaboration continued with the manufacture of oseltamivir tablets and the storage of more than five million packages of antivirals drugs during the H1N1 pandemic.\nIn 2014, due to the possibility of a nuclear risk situation, an agreement was signed with the Spanish Ministry of Home Affairs for the manufacture and supply of Potassium Iodide. During the COVID pandemic, as a consequence of being declared the Alert State, the capacities of the Spanish Military Pharmacy were made available to Operation Balmis.\nCollaboration with the Spanish Ministry of Health has been strengthened with the implementation of the Royal Decree which determines the application of the criteria and standards for the guarantee and rational use of medicines and healthcare products in the Spanish Armed Forces, by authorizing the Spanish Military Pharmacy to manufacture and distribute medicines in exceptional circumstances.\nWith regard to the storage and custody of the medicines and health products stock, it is a strength that the Spanish Military Pharmacy has available the Military Centre of Defence Pharmacy, Military Pharmacies and Military Pharmaceutical Warehouses deployed throughout the national territory.\n\nKeywords: Spanish Military Pharmacy; smallpox vaccines; Potassium Iodide; Operation Balmis; pandemic","PeriodicalId":50795,"journal":{"name":"Anales De La Real Academia Nacional De Farmacia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Military Pharmacy: A Tool to Support Civil Society\",\"authors\":\"Alejandro Zamanillo Sainz\",\"doi\":\"10.53519/analesranf.2024.90.02.01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The partnership between the Spanish Military Pharmacy Corps and the civil society has increased in the last twenty years, when the two million smallpox vaccines acquired by the Spanish Ministry of Health were stored at the “Centro Militar de Farmacia de la Defensa” (Military Centre of Defence Pharmacy). In 2009, collaboration continued with the manufacture of oseltamivir tablets and the storage of more than five million packages of antivirals drugs during the H1N1 pandemic.\\nIn 2014, due to the possibility of a nuclear risk situation, an agreement was signed with the Spanish Ministry of Home Affairs for the manufacture and supply of Potassium Iodide. During the COVID pandemic, as a consequence of being declared the Alert State, the capacities of the Spanish Military Pharmacy were made available to Operation Balmis.\\nCollaboration with the Spanish Ministry of Health has been strengthened with the implementation of the Royal Decree which determines the application of the criteria and standards for the guarantee and rational use of medicines and healthcare products in the Spanish Armed Forces, by authorizing the Spanish Military Pharmacy to manufacture and distribute medicines in exceptional circumstances.\\nWith regard to the storage and custody of the medicines and health products stock, it is a strength that the Spanish Military Pharmacy has available the Military Centre of Defence Pharmacy, Military Pharmacies and Military Pharmaceutical Warehouses deployed throughout the national territory.\\n\\nKeywords: Spanish Military Pharmacy; smallpox vaccines; Potassium Iodide; Operation Balmis; pandemic\",\"PeriodicalId\":50795,\"journal\":{\"name\":\"Anales De La Real Academia Nacional De Farmacia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anales De La Real Academia Nacional De Farmacia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53519/analesranf.2024.90.02.01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anales De La Real Academia Nacional De Farmacia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53519/analesranf.2024.90.02.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

过去二十年间,西班牙军方药房团与民间社会的合作不断加强,当时西班牙卫生部采购的 200 万支天花疫苗就储存在 "国防药房军事中心"(Centro Militar de Farmacia de la Defensa)。2009 年,继续合作生产奥司他韦药片,并在 H1N1 大流行期间储存了 500 多万包抗病毒药物。2014 年,由于可能出现核风险情况,与西班牙内政部签署了一项关于生产和供应碘化钾的协议。在 COVID 大流行期间,由于被宣布为戒备状态,西班牙军方药房的能力被提供给 Balmis 行动。随着皇家法令的实施,与西班牙卫生部的合作得到加强,该法令确定了在西班牙武装部队中保障和合理使用药品和保健产品的标准和规范,授权西班牙军方药房在特殊情况下制造和分发药品。在药品和保健品的储存和保管方面,西班牙军方药房的优势在于拥有部署在全国各地的军方国防药房中心、军方药房和军方药品仓库:西班牙军方药房;天花疫苗;碘化钾;巴尔米斯行动;大流行病
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Military Pharmacy: A Tool to Support Civil Society
The partnership between the Spanish Military Pharmacy Corps and the civil society has increased in the last twenty years, when the two million smallpox vaccines acquired by the Spanish Ministry of Health were stored at the “Centro Militar de Farmacia de la Defensa” (Military Centre of Defence Pharmacy). In 2009, collaboration continued with the manufacture of oseltamivir tablets and the storage of more than five million packages of antivirals drugs during the H1N1 pandemic. In 2014, due to the possibility of a nuclear risk situation, an agreement was signed with the Spanish Ministry of Home Affairs for the manufacture and supply of Potassium Iodide. During the COVID pandemic, as a consequence of being declared the Alert State, the capacities of the Spanish Military Pharmacy were made available to Operation Balmis. Collaboration with the Spanish Ministry of Health has been strengthened with the implementation of the Royal Decree which determines the application of the criteria and standards for the guarantee and rational use of medicines and healthcare products in the Spanish Armed Forces, by authorizing the Spanish Military Pharmacy to manufacture and distribute medicines in exceptional circumstances. With regard to the storage and custody of the medicines and health products stock, it is a strength that the Spanish Military Pharmacy has available the Military Centre of Defence Pharmacy, Military Pharmacies and Military Pharmaceutical Warehouses deployed throughout the national territory. Keywords: Spanish Military Pharmacy; smallpox vaccines; Potassium Iodide; Operation Balmis; pandemic
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.13
自引率
0.00%
发文量
7
期刊介绍: The Anales de la Real Academia Nacional de Farmacia� embraces all aspects of pharmaceutical sciences and is a quarterly journal that publishes basic and applied research on pharmaceutical sciences and related areas. It is a medium for reporting selected original and significant contributions to new pharmaceutical knowledge.
期刊最新文献
Therapeutic repositioning: importance of new therapeutic indications approved for old medicines The mRNA COVID 19 vaccine: More than a drug? Detection and management of a case of drug-resistant hypertension Galenic development of a capsule containing rosuvastatin, repaglinide, and olmesartan mini-tablets for the treatment of metabolic syndrome Novel drugs recently authorized by ema and fda (Q2, 2024)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1